These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29200014)

  • 1. Increased Delay Between Gadolinium Chelate Administration and T1-Weighted Magnetic Resonance Imaging Acquisition Increases Contrast-Enhancing Tumor Volumes and T1 Intensities in Brain Tumor Patients.
    Piechotta PL; Bonekamp D; Sill M; Wick A; Wick W; Bendszus M; Kickingereder P
    Invest Radiol; 2018 Apr; 53(4):223-228. PubMed ID: 29200014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging volumetric assessment of the extent of contrast enhancement and resection in oligodendroglial tumors.
    Sankar T; Moore NZ; Johnson J; Ashby LS; Scheck AC; Shapiro WR; Smith KA; Spetzler RF; Preul MC
    J Neurosurg; 2012 Jun; 116(6):1172-81. PubMed ID: 22424566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep-learning-based synthesis of post-contrast T1-weighted MRI for tumour response assessment in neuro-oncology: a multicentre, retrospective cohort study.
    Jayachandran Preetha C; Meredig H; Brugnara G; Mahmutoglu MA; Foltyn M; Isensee F; Kessler T; Pflüger I; Schell M; Neuberger U; Petersen J; Wick A; Heiland S; Debus J; Platten M; Idbaih A; Brandes AA; Winkler F; van den Bent MJ; Nabors B; Stupp R; Maier-Hein KH; Gorlia T; Tonn JC; Weller M; Wick W; Bendszus M; Vollmuth P
    Lancet Digit Health; 2021 Dec; 3(12):e784-e794. PubMed ID: 34688602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-delayed contrast-enhanced MRI improves detection of brain metastases and apparent treatment volumes.
    Kushnirsky M; Nguyen V; Katz JS; Steinklein J; Rosen L; Warshall C; Schulder M; Knisely JP
    J Neurosurg; 2016 Feb; 124(2):489-95. PubMed ID: 26361281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of Synthetic MRI for Direct Measurement of Magnetic Resonance Relaxation Time and Tumor Volume at Multiple Time Points after Contrast Administration: Preliminary Results in Patients with Brain Metastasis.
    Kang KM; Choi SH; Hwang M; Yoo RE; Yun TJ; Kim JH; Sohn CH
    Korean J Radiol; 2018; 19(4):783-791. PubMed ID: 29962885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is systematic Gadolinium injection relevant during MRI follow-up for non-functioning pituitary macroadenomas?
    Villemaire A; Adam G; Fayolle H; Roques M; Darcourt J; Caron P; Bonneville F
    J Neuroradiol; 2023 Feb; 50(1):3-8. PubMed ID: 36055429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of High-Field Intraoperative MRI in the Detectability of Residual Tumor in Glioma Grade IV Resections.
    Heßelmann V; Mager AK; Goetz C; Detsch O; Theisgen HK; Friese M; Schwindt W; Gottschalk J; Kremer P
    Rofo; 2017 Jun; 189(6):519-526. PubMed ID: 28591887
    [No Abstract]   [Full Text] [Related]  

  • 8. Can Virtual Contrast Enhancement in Brain MRI Replace Gadolinium?: A Feasibility Study.
    Kleesiek J; Morshuis JN; Isensee F; Deike-Hofmann K; Paech D; Kickingereder P; Köthe U; Rother C; Forsting M; Wick W; Bendszus M; Schlemmer HP; Radbruch A
    Invest Radiol; 2019 Oct; 54(10):653-660. PubMed ID: 31261293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of gadobutrol versus gadopentetate dimeglumine in enhanced MRI of brain metastases.
    Fan B; Li M; Wang X; Xu Y; Li F; Zhang L; Jiang J; Jiang Y
    J Magn Reson Imaging; 2017 Jun; 45(6):1827-1834. PubMed ID: 27696616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of immediate and delayed gadolinium-enhanced MRI after injection of 0.5 M and 1.0 M gadolinium chelates for detecting multiple sclerosis lesions.
    Uysal E; Erturk SM; Yildirim H; Seleker F; Basak M
    AJR Am J Roentgenol; 2007 Mar; 188(3):697-702. PubMed ID: 17312056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consecutive acquisition of time-resolved contrast-enhanced MR angiography and perfusion MR imaging with added dose of gadolinium-based contrast agent aids diagnosis of suspected brain metastasis.
    Tsuchiya K; Aoki S; Shimoji K; Mori H; Kunimatsu A
    Magn Reson Med Sci; 2013; 12(2):87-93. PubMed ID: 23666159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between contrast enhancement on fluid-attenuated inversion recovery MR sequences and signal intensity on T2-weighted MR images: visual evaluation of brain tumors.
    Kubota T; Yamada K; Kizu O; Hirota T; Ito H; Ishihara K; Nishimura T
    J Magn Reson Imaging; 2005 Jun; 21(6):694-700. PubMed ID: 15906343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of contrast-enhanced fluid-attenuated inversion-recovery MRI for intracranial tumors in comparison with post-contrast T1W spin-echo MRI.
    Zhou ZR; Shen TZ; Chen XR; Peng WJ
    Chin Med J (Engl); 2006 Mar; 119(6):467-73. PubMed ID: 16584644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smart forecasting of artifacts in contrast-enhanced breast MRI before contrast agent administration.
    Liebert A; Das BK; Kapsner LA; Eberle J; Skwierawska D; Folle L; Schreiter H; Laun FB; Ohlmeyer S; Uder M; Wenkel E; Bickelhaupt S
    Eur Radiol; 2024 Jul; 34(7):4752-4763. PubMed ID: 38099964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadolinium contrast medium administration does not adversely affect T2*-weighted gradient recalled echo magnetic resonance imaging of the canine brain at 1.5 Tesla.
    Bartels J; Hecht S; Conklin GA; Xiaocun S
    Vet Radiol Ultrasound; 2019 Mar; 60(2):184-191. PubMed ID: 30159943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cumulative Dose of Macrocyclic Gadolinium-Based Contrast Agent Improves Detection of Enhancing Lesions in Patients with Multiple Sclerosis.
    Rovira A; Auger C; Huerga E; Corral JF; Mitjana R; Sastre-Garriga J; Tintoré M; Montalban X
    AJNR Am J Neuroradiol; 2017 Aug; 38(8):1486-1493. PubMed ID: 28619842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic contrast enhancement of experimental glioma an intra-individual comparative study to assess the optimal time delay.
    Engelhorn T; Schwarz MA; Eyupoglu IY; Kloska SP; Struffert T; Doerfler A
    Acad Radiol; 2010 Feb; 17(2):188-93. PubMed ID: 19910218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing genomic and histologic correlations to radiographic changes in tumors: a murine SCC VII model study.
    Yang YS; Guccione S; Bednarski MD
    Acad Radiol; 2003 Oct; 10(10):1165-75. PubMed ID: 14587635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastoma.
    Hayes AR; Jayamanne D; Hsiao E; Schembri GP; Bailey DL; Roach PJ; Khasraw M; Newey A; Wheeler HR; Back M
    Pract Radiat Oncol; 2018; 8(4):230-238. PubMed ID: 29730279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra- and interobserver variability of linear and volumetric measurements of brain metastases using contrast-enhanced magnetic resonance imaging.
    Bauknecht HC; Romano VC; Rogalla P; Klingebiel R; Wolf C; Bornemann L; Hamm B; Hein PA
    Invest Radiol; 2010 Jan; 45(1):49-56. PubMed ID: 19996757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.